1,396
edits
(Importing a new version from external source) Tags: Mobile edit Mobile web edit |
(Importing a new version from external source) Tags: Mobile edit Mobile web edit |
||
Line 1: | Line 1: | ||
For authorisation of plant protection products, BVL draws on risk assessments by BfR, JKI and UBA. For the authorisation of veterinary medicinal products the expertise and responsibility are allocated at BVL. In both fields, BVL is involved in the establishment of maximum residue limits of active substances. | For authorisation of plant protection products, BVL draws on risk assessments by BfR, JKI and UBA. For the authorisation of veterinary medicinal products as well as risk communication regarding veterinary medicines, the expertise and responsibility are allocated at BVL. In both fields, BVL is involved in the establishment of maximum residue limits of active substances. Taking into account the risk assessments by other authorities, BVL decides on applications for the experimental scientific cultivation of genetically modified plants. Furthermore, BVL is involved in the EU marketing authorisation of genetically modified organisms (GMOs) in food and feed, feed additives and feedstuffs for particular nutritional purposes (dietetic feed). |
edits